Stimuli-Responsive Boron-Based Materials in Drug Delivery

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Feb 11

PMID 36769081

Authors

Bhaskar C Das

Parthiban Chokkalingam

Pavithra Masilamani

Srushti Shukla

Sasmita Das

Affiliations

Soon will be listed here.

Abstract

Drug delivery systems, which use components at the nanoscale level as diagnostic tools or to release therapeutic drugs to particular target areas in a regulated manner, are a fast-evolving field of science. The active pharmaceutical substance can be released via the drug delivery system to produce the desired therapeutic effect. The poor bioavailability and irregular plasma drug levels of conventional drug delivery systems (tablets, capsules, syrups, etc.) prevent them from achieving sustained delivery. The entire therapy process may be ineffective without a reliable delivery system. To achieve optimal safety and effectiveness, the drug must also be administered at a precision-controlled rate and the targeted spot. The issues with traditional drug delivery are overcome by the development of stimuli-responsive controlled drug release. Over the past decades, regulated drug delivery has evolved considerably, progressing from large- and nanoscale to smart-controlled drug delivery for several diseases. The current review provides an updated overview of recent developments in the field of stimuli-responsive boron-based materials in drug delivery for various diseases. Boron-containing compounds such as boron nitride, boronic acid, and boron dipyrromethene have been developed as a moving field of research in drug delivery. Due to their ability to achieve precise control over drug release through the response to particular stimuli (pH, light, glutathione, glucose or temperature), stimuli-responsive nanoscale drug delivery systems are attracting a lot of attention. The potential of developing their capabilities to a wide range of nanoscale systems, such as nanoparticles, nanosheets/nanospheres, nanotubes, nanocarriers, microneedles, nanocapsules, hydrogel, nanoassembly, etc., is also addressed and examined. This review also provides overall design principles to include stimuli-responsive boron nanomaterial-based drug delivery systems, which might inspire new concepts and applications.

Citing Articles

Reversible light-responsive protein hydrogel for on-demand cell encapsulation and release.

Narayan O, Dong J, Huang M, Chen L, Liu L, Nguyen V Acta Biomater. 2025; 193:202-214.

PMID: 39800098 PMC: 11847564. DOI: 10.1016/j.actbio.2025.01.012.

Boronate Ester Hydrogels for Biomedical Applications: Challenges and Opportunities.

Terriac L, Helesbeux J, Maugars Y, Guicheux J, Tibbitt M, Delplace V Chem Mater. 2024; 36(14):6674-6695.

PMID: 39070669 PMC: 11270748. DOI: 10.1021/acs.chemmater.4c00507.

Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes.

Das B, Chokkalingam P, Shareef M, Shukla S, Das S, Saito M J Eukaryot Microbiol. 2024; 71(5):e13036.

PMID: 39036929 PMC: 11576263. DOI: 10.1111/jeu.13036.

An ethyl cellulose novel biodegradable flexible substrate material for sustainable screen-printing.

Palmieri E, Cancelliere R, Maita F, Micheli L, Maiolo L RSC Adv. 2024; 14(25):18103-18108.

PMID: 38847004 PMC: 11154189. DOI: 10.1039/d4ra02993c.

A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides.

Ermini E, Brai A, Cini E, Finetti F, Giannini G, Padula D Chem Sci. 2024; 15(16):6168-6177.

PMID: 38665538 PMC: 11041255. DOI: 10.1039/d4sc01576b.

References

Khatti Z, Hashemianzadeh S . Boron nitride nanotube as a delivery system for platinum drugs: Drug encapsulation and diffusion coefficient prediction. Eur J Pharm Sci. 2016; 88:291-7. DOI: 10.1016/j.ejps.2016.04.011. View

Pantarotto D, Briand J, Prato M, Bianco A . Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb). 2004; (1):16-7. DOI: 10.1039/b311254c. View

Zhi X, Zheng C, Xiong J, Li J, Zhao C, Shi L . Nanofilamentous Virus-Based Dynamic Hydrogels with Tunable Internal Structures, Injectability, Self-Healing, and Sugar Responsiveness at Physiological pH. Langmuir. 2018; 34(43):12914-12923. DOI: 10.1021/acs.langmuir.8b02526. View

Kojima C, Kono K, Maruyama K, TAKAGISHI T . Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem. 2000; 11(6):910-7. DOI: 10.1021/bc0000583. View

Dunn M . Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review. Biometals. 2005; 18(4):295-303. DOI: 10.1007/s10534-005-3685-y. View

Hariri G, Yan H, Wang H, Han Z, Hallahan D . Radiation-guided drug delivery to mouse models of lung cancer. Clin Cancer Res. 2010; 16(20):4968-77. PMC: 2955851. DOI: 10.1158/1078-0432.CCR-10-0969. View

Shen D, Yu H, Wang L, Khan A, Haq F, Chen X . Recent progress in design and preparation of glucose-responsive insulin delivery systems. J Control Release. 2020; 321:236-258. DOI: 10.1016/j.jconrel.2020.02.014. View

Kucukdogru R, Turkez H, Arslan M, Tozlu O, Sonmez E, Mardinoglu A . Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson's disease model against MPP+ induced apoptosis. Metab Brain Dis. 2020; 35(6):947-957. DOI: 10.1007/s11011-020-00559-6. View

Kunjachan S, Rychlik B, Storm G, Kiessling F, Lammers T . Multidrug resistance: Physiological principles and nanomedical solutions. Adv Drug Deliv Rev. 2013; 65(13-14):1852-1865. PMC: 3939439. DOI: 10.1016/j.addr.2013.09.018. View

10.

Senapati S, Mahanta A, Kumar S, Maiti P . Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018; 3:7. PMC: 5854578. DOI: 10.1038/s41392-017-0004-3. View

11.

Panyam J, Labhasetwar V . Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003; 55(3):329-47. DOI: 10.1016/s0169-409x(02)00228-4. View

12.

Kumar R, Han J, Lim H, Ren W, Lim J, Kim J . Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment. J Am Chem Soc. 2014; 136(51):17836-43. DOI: 10.1021/ja510421q. View

13.

Duncan R, Spreafico F . Polymer conjugates. Pharmacokinetic considerations for design and development. Clin Pharmacokinet. 1994; 27(4):290-306. DOI: 10.2165/00003088-199427040-00004. View

14.

Li J, Dirisala A, Ge Z, Wang Y, Yin W, Ke W . Therapeutic Vesicular Nanoreactors with Tumor-Specific Activation and Self-Destruction for Synergistic Tumor Ablation. Angew Chem Int Ed Engl. 2017; 56(45):14025-14030. DOI: 10.1002/anie.201706964. View

15.

Milla P, Dosio F, Cattel L . PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab. 2011; 13(1):105-19. DOI: 10.2174/138920012798356934. View

16.

Patel V, Agrawal Y . Nanosuspension: An approach to enhance solubility of drugs. J Adv Pharm Technol Res. 2011; 2(2):81-7. PMC: 3217698. DOI: 10.4103/2231-4040.82950. View

17.

Devarakonda B, Hill R, de Villiers M . The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm. 2004; 284(1-2):133-40. DOI: 10.1016/j.ijpharm.2004.07.006. View

18.

Lee W, Loo C, Bebawy M, Luk F, Mason R, Rohanizadeh R . Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol. 2014; 11(4):338-78. PMC: 3744901. DOI: 10.2174/1570159X11311040002. View

19.

Venugopal J, Ramakrishna S . Applications of polymer nanofibers in biomedicine and biotechnology. Appl Biochem Biotechnol. 2005; 125(3):147-58. DOI: 10.1385/abab:125:3:147. View

20.

Zhao H, Li L, Zheng C, Hao Y, Niu M, Hu Y . An intelligent dual stimuli-responsive photosensitizer delivery system with O-supplying for efficient photodynamic therapy. Colloids Surf B Biointerfaces. 2018; 167:299-309. DOI: 10.1016/j.colsurfb.2018.04.011. View